# Unitil Corp: financial statements, quarterly

UTL · NYSE · CIK 755001 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/utl.md) · [Financials](/companies/utl/financials.md) · [Filings](/companies/utl/filings.md) · [Insiders](/companies/utl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/utl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [104](/filings/0000950170-24-120859.md) | [130 d](/filings/0001193125-26-042983.md) | [179](/filings/0000950170-25-064590.md) | [95.7](/filings/0000950170-25-102121.md) | [92.9](/filings/0001193125-25-262745.md) | [128 d](/filings/0001193125-26-042983.md) | [171](/filings/0000755001-26-000010.md) | [103](/filings/0000755001-26-000029.md) | [101](/filings/0001193125-25-262745.md) | [162 d](/filings/0001193125-26-042983.md) | [217](/filings/0000755001-26-000010.md) | [117](/filings/0000755001-26-000029.md) |
| Operating income | $m | [8.0](/filings/0000950170-24-120859.md) | [27.8 d](/filings/0001193125-26-042983.md) | [44.2](/filings/0000950170-25-064590.md) | [12.4](/filings/0000950170-25-102121.md) | [5.8](/filings/0001193125-25-262745.md) | [28.2 d](/filings/0001193125-26-042983.md) | [46.2](/filings/0000755001-26-000010.md) | [13.3](/filings/0000755001-26-000029.md) | [7.0](/filings/0001193125-25-262745.md) | [34.7 d](/filings/0001193125-26-042983.md) | [55.9](/filings/0000755001-26-000010.md) | [15.4](/filings/0000755001-26-000029.md) |
| Income tax | $m | [(0.4)](/filings/0000950170-24-120859.md) | [4.6 d](/filings/0001193125-26-042983.md) | [9.4](/filings/0000950170-25-064590.md) | [0.6](/filings/0000950170-25-102121.md) | [(1.3)](/filings/0001193125-25-262745.md) | [5.3 d](/filings/0001193125-26-042983.md) | [9.5](/filings/0000755001-26-000010.md) | [0.7](/filings/0000755001-26-000029.md) | [(1.3)](/filings/0001193125-25-262745.md) | [6.4 d](/filings/0001193125-26-042983.md) | [11.9](/filings/0000755001-26-000010.md) | [1.1](/filings/0000755001-26-000029.md) |
| Net income | $m | [1.4](/filings/0000950170-24-120859.md) | [15.5 d](/filings/0001193125-26-042983.md) | [27.2](/filings/0000950170-25-064590.md) | [4.3](/filings/0000950170-25-102121.md) | [0.0](/filings/0001193125-25-262745.md) | [15.6 d](/filings/0001193125-26-042983.md) | [27.5](/filings/0000755001-26-000010.md) | [4.0](/filings/0000755001-26-000029.md) | [(0.3)](/filings/0001193125-25-262745.md) | [19.0 d](/filings/0001193125-26-042983.md) | [33.2](/filings/0000755001-26-000010.md) | [4.7](/filings/0000755001-26-000029.md) |
| Diluted EPS | $ per share | [0.09](/filings/0000950170-24-120859.md) | not reported | [1.69](/filings/0000950170-25-064590.md) | [0.27](/filings/0000950170-25-102121.md) | [0.00](/filings/0001193125-25-262745.md) | not reported | [1.69](/filings/0000755001-26-000010.md) | [0.25](/filings/0000755001-26-000029.md) | [(0.02)](/filings/0001193125-25-262745.md) | not reported | [1.85](/filings/0000755001-26-000010.md) | [0.26](/filings/0000755001-26-000029.md) |
| Basic EPS | $ per share | [0.09](/filings/0000950170-24-120859.md) | not reported | [1.69](/filings/0000950170-25-064590.md) | [0.27](/filings/0000950170-25-102121.md) | [0.00](/filings/0001193125-25-262745.md) | not reported | [1.69](/filings/0000755001-26-000010.md) | [0.25](/filings/0000755001-26-000029.md) | [(0.02)](/filings/0001193125-25-262745.md) | not reported | [1.85](/filings/0000755001-26-000010.md) | [0.26](/filings/0000755001-26-000029.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [6.0](/filings/0000950170-24-120859.md) | [6.5](/filings/0000950170-25-017154.md) | [6.3](/filings/0000950170-25-064590.md) | [2.8](/filings/0000950170-25-102121.md) | [6.3](/filings/0001193125-25-262745.md) | [6.3](/filings/0001193125-26-042983.md) | [10.2](/filings/0000755001-26-000010.md) | [8.5](/filings/0000755001-26-000029.md) | [14.6](/filings/0001193125-25-262745.md) | [15.6](/filings/0000755001-26-000029.md) | [16.9](/filings/0000755001-26-000010.md) | [9.2](/filings/0000755001-26-000029.md) |
| Current assets | $m | [156](/filings/0000950170-24-120859.md) | [177](/filings/0000950170-25-017154.md) | [189](/filings/0000950170-25-064590.md) | [160](/filings/0000950170-25-102121.md) | [163](/filings/0001193125-25-262745.md) | [189](/filings/0001193125-26-042983.md) | [196](/filings/0000755001-26-000010.md) | [170](/filings/0000755001-26-000029.md) | [184](/filings/0001193125-25-262745.md) | [240](/filings/0000755001-26-000029.md) | [237](/filings/0000755001-26-000010.md) | [199](/filings/0000755001-26-000029.md) |
| Total assets | $m | [1,620](/filings/0000950170-24-120859.md) | [1,670](/filings/0000950170-25-017154.md) | [1,698](/filings/0000950170-25-064590.md) | [1,695](/filings/0000950170-25-102121.md) | [1,737](/filings/0001193125-25-262745.md) | [1,795](/filings/0001193125-26-042983.md) | [1,891](/filings/0000755001-26-000010.md) | [1,893](/filings/0000755001-26-000029.md) | [1,945](/filings/0001193125-25-262745.md) | [2,134](/filings/0000755001-26-000029.md) | [2,156](/filings/0000755001-26-000010.md) | [2,221](/filings/0000755001-26-000029.md) |
| Current liabilities | $m | [243](/filings/0000950170-24-120859.md) | [277](/filings/0000950170-25-017154.md) | [277](/filings/0000950170-25-064590.md) | [274](/filings/0000950170-25-102121.md) | [179](/filings/0001193125-25-262745.md) | [229](/filings/0001193125-26-042983.md) | [295](/filings/0000755001-26-000010.md) | [294](/filings/0000755001-26-000029.md) | [275](/filings/0001193125-25-262745.md) | [426](/filings/0000755001-26-000029.md) | [416](/filings/0000755001-26-000010.md) | [405](/filings/0000755001-26-000029.md) |
| Long-term debt | $m | [509](/filings/0000950170-24-120859.md) | [509](/filings/0000950170-25-017154.md) | [508](/filings/0000950170-25-064590.md) | [506](/filings/0000950170-25-102121.md) | [638](/filings/0001193125-25-262745.md) | [638](/filings/0001193125-26-042983.md) | [637](/filings/0000755001-26-000010.md) | [636](/filings/0000755001-26-000029.md) | [636](/filings/0001193125-25-262745.md) | [633](/filings/0000755001-26-000029.md) | [631](/filings/0000755001-26-000010.md) | [680](/filings/0000755001-26-000029.md) |
| Current portion of debt | $m | [7.0](/filings/0000950170-24-120859.md) | [4.9](/filings/0000950170-25-017154.md) | [4.9](/filings/0000950170-25-064590.md) | [4.9](/filings/0000950170-25-102121.md) | [4.9](/filings/0001193125-25-262745.md) | [4.9](/filings/0001193125-26-042983.md) | [4.9](/filings/0000755001-26-000010.md) | [4.9](/filings/0000755001-26-000029.md) | [34.9](/filings/0001193125-25-262745.md) | [37.9](/filings/0000755001-26-000029.md) | [37.9](/filings/0000755001-26-000010.md) | [40.8](/filings/0000755001-26-000029.md) |
| Short-term borrowings | $m | [130](/filings/0000950170-24-120859.md) | [162](/filings/0000950170-25-017154.md) | [170](/filings/0000950170-25-064590.md) | [158](/filings/0000950170-25-102121.md) | [64.3](/filings/0001193125-25-262745.md) | [106](/filings/0001193125-26-042983.md) | [173](/filings/0000755001-26-000010.md) | [171](/filings/0000755001-26-000029.md) | [118](/filings/0001193125-25-262745.md) | [256](/filings/0000755001-26-000029.md) | [258](/filings/0000755001-26-000010.md) | [235](/filings/0000755001-26-000029.md) |
| Shareholders' equity | $m | [480](/filings/0000950170-24-120859.md) | [489](/filings/0000950170-25-064590.md) | [511](/filings/0000950170-25-064590.md) | [509](/filings/0000950170-25-102121.md) | [502](/filings/0001193125-25-262745.md) | [513](/filings/0001193125-26-042983.md) | [534](/filings/0000755001-26-000010.md) | [533](/filings/0000755001-26-000029.md) | [597](/filings/0001193125-25-262745.md) | [610](/filings/0000755001-26-000029.md) | [636](/filings/0000755001-26-000010.md) | [644](/filings/0000755001-26-000029.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [16.3 d](/filings/0000950170-24-120859.md) | [28.3 d](/filings/0001193125-26-042983.md) | [26.6](/filings/0000950170-25-064590.md) | [49.9 d](/filings/0000950170-25-102121.md) | [26.1 d](/filings/0001193125-25-262745.md) | [23.3 d](/filings/0001193125-26-042983.md) | [52.1](/filings/0000755001-26-000010.md) | [42.2 d](/filings/0000755001-26-000029.md) | [15.6 d](/filings/0001193125-25-262745.md) | [21.4 d](/filings/0001193125-26-042983.md) | [50.1](/filings/0000755001-26-000010.md) | [55.7 d](/filings/0000755001-26-000029.md) |
| Capital expenditure | $m | [35.8](/filings/0000950170-24-120859.md) | [47.6 d](/filings/0001193125-26-042983.md) | [20.2](/filings/0000950170-25-064590.md) | [36.7](/filings/0000950170-24-091194.md) | [57.4](/filings/0000950170-24-120859.md) | [55.6 d](/filings/0001193125-26-042983.md) | [32.6](/filings/0000755001-26-000010.md) | [40.2 d](/filings/0000755001-26-000029.md) | [54.6 d](/filings/0001193125-25-262745.md) | [57.7 d](/filings/0001193125-26-042983.md) | [32.4](/filings/0000755001-26-000010.md) | [43.6 d](/filings/0000755001-26-000029.md) |
| Dividends paid | $m | [6.5 d](/filings/0000950170-24-120859.md) | [6.6 d](/filings/0001193125-26-042983.md) | [6.8](/filings/0000950170-25-064590.md) | [6.9 d](/filings/0000950170-25-102121.md) | [6.9 d](/filings/0001193125-25-262745.md) | [6.9 d](/filings/0001193125-26-042983.md) | [7.3](/filings/0000755001-26-000010.md) | [7.3 d](/filings/0000755001-26-000029.md) | [7.4 d](/filings/0001193125-25-262745.md) | [8.1 d](/filings/0001193125-26-042983.md) | [8.5](/filings/0000755001-26-000010.md) | [8.6 d](/filings/0000755001-26-000029.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [16.0](/filings/0000950170-23-059748.md) | [16.0](/filings/0000950170-24-053926.md) | [16.0](/filings/0000950170-24-091194.md) | [16.1](/filings/0000950170-24-120859.md) | [16.1](/filings/0000950170-25-064590.md) | [16.1](/filings/0000950170-25-102121.md) | [16.1](/filings/0001193125-25-262745.md) | [16.2](/filings/0000755001-26-000010.md) | [16.2](/filings/0000755001-26-000029.md) | [17.0](/filings/0001193125-25-262745.md) | [17.9](/filings/0000755001-26-000010.md) | [17.9](/filings/0000755001-26-000029.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 18,236,674 at 2026-07-31, from the cover of the [10-Q filed 2026-08-03](/filings/0000755001-26-000029.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.